Amniotic band syndrome: A single-institutional experience

Corey W. Iqbal, S. Christopher Derderian, Yvonne Cheng, Hanmin Lee, Shinjiro Hirose

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Amniotic band syndrome (ABS) is uncommon. We review our single-institutional experience to define its natural history and outcomes. Materials andMethods: We conducted a retrospective analysis from a single, tertiary referral center of patients evaluated for and confirmed to have ABS from 1997 to 2012. Results: Twenty-eight patients had confirmed ABS. The mean ± SD maternal age was 27.9 ± 5.9 years, and the mean gestational age at diagnosis was 20.7 ± 3.8 months. Oligohydramnios was reported in 4 patients. Eleven patients had membrane disruption, of whom 4 had undergone a prior percutaneous intervention. Extremities were the most common site affected (n = 20), followed by the umbilical cord (n = 7), abdomen (n = 5), limb-body wall complex (n = 5), head (n = 1), and chest (n = 1). Nine patients were felt to be candidates for fetal intervention; 5 underwent fetoscopic amniotic band lysis with 4 survivors. Overall survival, excluding 3 terminations, was 74%. There were 5 fetal demises and one neonatal death. Cord involvement was higher in nonsurvivors (67%) compared to survivors (19%, p = 0.05). Discussion: ABS most commonly involves the extremities. Membrane disruption is not always present. Fetoscopic lysis is appropriate for select patients, and special consideration should be given for cord involvement, which is associated with a worse outcome.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalFetal Diagnosis and Therapy
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Amniotic Band Syndrome
Extremities
Survivors
Oligohydramnios
Membranes
Umbilical Cord
Maternal Age
Natural History
Tertiary Care Centers
Abdomen
Gestational Age
Thorax
Head
Survival

Keywords

  • Amniotic band
  • Amniotic band syndrome
  • Complicated pregnancy
  • Limb-body wall complex

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology

Cite this

Amniotic band syndrome : A single-institutional experience. / Iqbal, Corey W.; Christopher Derderian, S.; Cheng, Yvonne; Lee, Hanmin; Hirose, Shinjiro.

In: Fetal Diagnosis and Therapy, Vol. 37, No. 1, 01.01.2015, p. 1-5.

Research output: Contribution to journalArticle

Iqbal, CW, Christopher Derderian, S, Cheng, Y, Lee, H & Hirose, S 2015, 'Amniotic band syndrome: A single-institutional experience', Fetal Diagnosis and Therapy, vol. 37, no. 1, pp. 1-5. https://doi.org/10.1159/000358301
Iqbal, Corey W. ; Christopher Derderian, S. ; Cheng, Yvonne ; Lee, Hanmin ; Hirose, Shinjiro. / Amniotic band syndrome : A single-institutional experience. In: Fetal Diagnosis and Therapy. 2015 ; Vol. 37, No. 1. pp. 1-5.
@article{87b7f3ce6e1f4bb8b01b27ce86cda935,
title = "Amniotic band syndrome: A single-institutional experience",
abstract = "Introduction: Amniotic band syndrome (ABS) is uncommon. We review our single-institutional experience to define its natural history and outcomes. Materials andMethods: We conducted a retrospective analysis from a single, tertiary referral center of patients evaluated for and confirmed to have ABS from 1997 to 2012. Results: Twenty-eight patients had confirmed ABS. The mean ± SD maternal age was 27.9 ± 5.9 years, and the mean gestational age at diagnosis was 20.7 ± 3.8 months. Oligohydramnios was reported in 4 patients. Eleven patients had membrane disruption, of whom 4 had undergone a prior percutaneous intervention. Extremities were the most common site affected (n = 20), followed by the umbilical cord (n = 7), abdomen (n = 5), limb-body wall complex (n = 5), head (n = 1), and chest (n = 1). Nine patients were felt to be candidates for fetal intervention; 5 underwent fetoscopic amniotic band lysis with 4 survivors. Overall survival, excluding 3 terminations, was 74{\%}. There were 5 fetal demises and one neonatal death. Cord involvement was higher in nonsurvivors (67{\%}) compared to survivors (19{\%}, p = 0.05). Discussion: ABS most commonly involves the extremities. Membrane disruption is not always present. Fetoscopic lysis is appropriate for select patients, and special consideration should be given for cord involvement, which is associated with a worse outcome.",
keywords = "Amniotic band, Amniotic band syndrome, Complicated pregnancy, Limb-body wall complex",
author = "Iqbal, {Corey W.} and {Christopher Derderian}, S. and Yvonne Cheng and Hanmin Lee and Shinjiro Hirose",
year = "2015",
month = "1",
day = "1",
doi = "10.1159/000358301",
language = "English (US)",
volume = "37",
pages = "1--5",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Amniotic band syndrome

T2 - A single-institutional experience

AU - Iqbal, Corey W.

AU - Christopher Derderian, S.

AU - Cheng, Yvonne

AU - Lee, Hanmin

AU - Hirose, Shinjiro

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction: Amniotic band syndrome (ABS) is uncommon. We review our single-institutional experience to define its natural history and outcomes. Materials andMethods: We conducted a retrospective analysis from a single, tertiary referral center of patients evaluated for and confirmed to have ABS from 1997 to 2012. Results: Twenty-eight patients had confirmed ABS. The mean ± SD maternal age was 27.9 ± 5.9 years, and the mean gestational age at diagnosis was 20.7 ± 3.8 months. Oligohydramnios was reported in 4 patients. Eleven patients had membrane disruption, of whom 4 had undergone a prior percutaneous intervention. Extremities were the most common site affected (n = 20), followed by the umbilical cord (n = 7), abdomen (n = 5), limb-body wall complex (n = 5), head (n = 1), and chest (n = 1). Nine patients were felt to be candidates for fetal intervention; 5 underwent fetoscopic amniotic band lysis with 4 survivors. Overall survival, excluding 3 terminations, was 74%. There were 5 fetal demises and one neonatal death. Cord involvement was higher in nonsurvivors (67%) compared to survivors (19%, p = 0.05). Discussion: ABS most commonly involves the extremities. Membrane disruption is not always present. Fetoscopic lysis is appropriate for select patients, and special consideration should be given for cord involvement, which is associated with a worse outcome.

AB - Introduction: Amniotic band syndrome (ABS) is uncommon. We review our single-institutional experience to define its natural history and outcomes. Materials andMethods: We conducted a retrospective analysis from a single, tertiary referral center of patients evaluated for and confirmed to have ABS from 1997 to 2012. Results: Twenty-eight patients had confirmed ABS. The mean ± SD maternal age was 27.9 ± 5.9 years, and the mean gestational age at diagnosis was 20.7 ± 3.8 months. Oligohydramnios was reported in 4 patients. Eleven patients had membrane disruption, of whom 4 had undergone a prior percutaneous intervention. Extremities were the most common site affected (n = 20), followed by the umbilical cord (n = 7), abdomen (n = 5), limb-body wall complex (n = 5), head (n = 1), and chest (n = 1). Nine patients were felt to be candidates for fetal intervention; 5 underwent fetoscopic amniotic band lysis with 4 survivors. Overall survival, excluding 3 terminations, was 74%. There were 5 fetal demises and one neonatal death. Cord involvement was higher in nonsurvivors (67%) compared to survivors (19%, p = 0.05). Discussion: ABS most commonly involves the extremities. Membrane disruption is not always present. Fetoscopic lysis is appropriate for select patients, and special consideration should be given for cord involvement, which is associated with a worse outcome.

KW - Amniotic band

KW - Amniotic band syndrome

KW - Complicated pregnancy

KW - Limb-body wall complex

UR - http://www.scopus.com/inward/record.url?scp=84922331373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922331373&partnerID=8YFLogxK

U2 - 10.1159/000358301

DO - 10.1159/000358301

M3 - Article

C2 - 25531236

AN - SCOPUS:84922331373

VL - 37

SP - 1

EP - 5

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 1

ER -